PROSPER: Phase III RandOmized Study Comparing PERioperative nivolumab versus observation in patients with renal cell carcinoma (RCC) undergoing nephrectomy (ECOG-ACRIN EA8143).

被引：8

作者：

Allaf, Mohamad E.

Kim, Se Eun

Master, Viraj A.

McDermott, David F.

Signoretti, Sabina

Cella, David

Gupta, Rajan T.

Cole, Suzanne

Shuch, Brian M.

Lara, Primo

Kapoor, Anil

Heng, Daniel Yick Chin

Leibovich, Bradley C.

Michaelson, M. Dror

Choueiri, Toni K.

Jewett, Michael A. S.

Maskens, Deb

Harshman, Lauren C.

Carducci, Michael Anthony

Haas, Naomi B.

机构：

[1] Johns Hopkins, HaasJames Buchanan Brady Urol Inst, Dept Urol, Sch Med, Baltimore, MD USA

[2] Dana Farber Canc Inst, ECOG, ACRIN Biostat Ctr, Boston, MA USA

[3] Winship Canc Inst Emory Univ, Atlanta, GA USA

[4] Beth Israel Deaconess Med Ctr, Dana Farber Harvard Canc Ctr, Boston, MA USA

[5] Brigham & Womens Hosp, Boston, MA USA

[6] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL USA

[7] Duke Univ, Med Ctr, Durham, NC USA

[8] UT SouthWestern, Med Ctr, Dallas, TX USA

[9] Yale Sch Med, New Haven, CT USA

[10] Univ Calif Sacramento, Sacramento, CA USA

[11] McMaster Univ, Juravinski Canc Ctr, Hamilton, ON, Canada

[12] Univ Calgary, Tom Baker Canc Ctr, Calgary, AB, Canada

[13] Mayo Clin, Rochester, MN USA

[14] Massachusetts Gen Hosp, Boston, MA USA

[15] Dana Farber Canc Inst, Lank Ctr Genitourinary Oncol, Boston, MA USA

[16] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada

[17] Kidney Canc Canada, Toronto, ON, Canada

[18] Stanford Univ, Sch Med, Stanford, CA USA

[19] Johns Hopkins Univ, Sidney Kimmel Canc Ctr, Sch Med, Baltimore, MD USA

[20] Univ Penn, Abramson Canc Ctr, ECOG ACRIN, Philadelphia, PA USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期

关键词：

D O I：

10.1200/JCO.2021.39.15_suppl.TPS4596

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

TPS4596

引用

页数：3